A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...

I’d rather be at home doing it for myself.” Boynton used the self-injectable version of Depo-Provera for nearly 2 years and ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...

A fear of needles in a medical setting (often called trypanophobia when it’s more severe) is common and can make TRT injections feel intimidating, but understanding why it happens can make it easier ...

Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a ...

It’s been more than 10 years since the FDA signed off on the U.S.’ first biosimilar product, opening up what was originally expected to be an easily accessible, cheaper drug market featuring ...

Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 weeks, according to data published in Arthritis & Rheumatology.“As a ...

The pandemic changed how Americans think about health — and who they trust to manage it. In the wreckage of lockdowns, millions turned away from doctors and toward influencers. Now, a growing number ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick up the medicine every few weeks. It would be easier for them to be able to ...

Subcutaneous Saphnelo may offer people with lupus more convenient dosing with efficacy similar to the approved infusion version of the therapy, data show.